Can I Take Mounjaro If I Have Kidney Disease? (October 2026)

01 · The core answer

Can you take Mounjaro with kidney disease?

For many people with kidney disease the answer is yes, with sensible precautions. Mounjaro is not known to damage kidneys or liver directly, and no dose adjustment is needed for mild to moderate kidney or liver impairment.¹¹¹ People with severe impairment need individual prescriber assessment, so a blanket yes or no would not be honest.¹

02 · What you are deciding

The decisions you are actually facing

Most readers are weighing up two questions. First, does my level of kidney disease change whether I can start? Second, if I do start, what do I need to do differently day to day?

On the first question, the dividing line in the product information is between mild to moderate impairment and severe impairment. Mild to moderate means no dose adjustment is needed. Severe means an individual assessment is required, and that assessment belongs with a prescriber who can see your full history rather than with a web page.¹

On the second question, the answer is mainly about fluids. Keep them up, and get medical help straight away if you cannot keep fluids down.¹³ Your prescriber also needs your full medical history and medicine list, because other conditions and medicines can change the picture.¹

03 · What to do next

What to do next

If you have kidney disease and are considering treatment, the safest route is a proper consultation in which you declare it clearly. Our free online consultation is reviewed by a GPhC-registered prescriber. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.

If your kidney disease is at a moderate stage, our page on kidney disease at a moderate stage goes into the same questions in more depth. If you want to compare medicines, see our overview of GLP-1 options for kidney disease. Whatever you choose, do not stop or change any kidney medicine yourself; your own kidney team should be told about any new treatment.

04 · What the label says

What the product information says about kidneys

The product information says Mounjaro is not known to damage kidneys or liver directly. It also says no dose adjustment is needed for mild to moderate kidney or liver impairment, while people with severe impairment need individual prescriber assessment.¹¹¹

The first clause, not known to damage the kidneys directly, is reassuring but carefully worded. It does not say the medicine can never affect your kidneys by any route. It says the medicine is not known to injure kidney tissue itself. The second clause, no dose adjustment for mild to moderate impairment, tells your prescriber they can use the usual stepped dose schedule rather than inventing a special lower one. The third clause, individual assessment for severe impairment, is the safety valve: where kidney function is badly reduced, the decision is personal rather than automatic.

Mounjaro is not a kidney treatment. Mounjaro is licensed in the UK for weight management in adults and for type 2 diabetes, and it is used alongside a reduced-calorie diet and increased physical activity.¹ If a website tells you it is a kidney treatment, treat that as marketing rather than medicine.

Why does this matter to you? Because many people with kidney disease also have type 2 diabetes, raised blood pressure or excess weight, and they are told several things at once by different clinicians. A clear, narrow reading of the label stops you over-promising to yourself. The medicine is not a kidney therapy, it is not known to harm the kidneys directly, and the main thing to manage is fluid balance.

The patient information leaflet that comes in every box repeats the dehydration advice.¹³ Read it before your first injection rather than after a bad week, and keep it somewhere you can find it. If anything in it seems to clash with advice from your kidney team, ask before you inject rather than assuming one of them is wrong.

Our pages for related situations follow the same logic. If you have a single working kidney, see if you have only one kidney; if your concern is stones rather than reduced function, see kidney stones and Mounjaro.

05 · Dehydration risk

Why dehydration is the practical risk

The risk that matters most is indirect: severe vomiting or diarrhoea can cause dehydration, which can strain the kidneys.¹

Mounjaro works by activating the GIP and GLP-1 receptors, which helps regulate appetite and slows how quickly the stomach empties.¹ Slower stomach emptying is part of why people feel full sooner. For most people these effects are mild and settle. The concern is the minority who lose fluids faster than they can replace them.

If you have kidney disease, think about hydration as part of your treatment plan rather than an afterthought. Practical points that follow directly from the label advice:

• Keep your fluids up through the whole course, not only when you feel unwell.
• If you are being sick or have diarrhoea and cannot keep fluids down, get medical help straight away rather than waiting to see whether it passes.
• If you have ongoing vomiting or diarrhoea, contact your clinical team so they can consider your next dose.
• Do not push through a dose increase while you are still struggling with the previous step.

That last point links to how the medicine is started. Treatment begins on the lowest strength and steps up over time rather than starting at a high dose. People with kidney disease, who have less margin for fluid loss, are exactly the people for whom a patient, unhurried approach to stepping up makes sense. Your prescriber is the person who decides pace; our aftercare includes ongoing monthly reviews and side-effect support from the prescribing team.

It is also sensible to be aware of the other warning signs in the product information. Severe, persistent stomach pain that may spread to your back, with or without vomiting, needs immediate medical help, as does pain in the upper right abdomen with fever or yellowing of the skin or eyes.¹

You can report any suspected side effect through the MHRA Yellow Card scheme.¹⁹

06 · Severe impairment

When kidney impairment is severe

If your kidney impairment is severe, there is no automatic yes or no: the product information says you need individual prescriber assessment.¹

What does individual assessment mean in practice? It means a clinician looking at the whole picture rather than ticking a box. They will want to understand how your kidney disease has behaved, what other conditions you have, which medicines you take and how well you currently tolerate eating, drinking and everyday life. They will also weigh what you hope to gain from weight management against the possibility of side effects that cause fluid loss. Because that weighing is personal, two people with similar kidney numbers can reasonably receive different advice.

For this reason we encourage anyone with severe kidney disease to involve the team who already look after their kidneys. A specialist who knows your trends may have views on timing, monitoring or whether weight management through a different route suits you better. Bring them the product information and ask directly. If they advise against treatment, that is a legitimate outcome, and an unsuitable order with us is refunded automatically rather than dispensed.

Everything about our consultation is designed around this principle. It is a short health questionnaire, free and with no obligation, and it is reviewed by a GPhC-registered prescriber who is making a clinical judgement. You should answer the kidney questions fully and precisely, including anything you are unsure about. If you are unsure of your stage, say so; the prescriber would rather have honest uncertainty than a tidy-looking guess.

Where kidney disease is present together with other conditions, the same careful reading applies. For instance, our page on digestive conditions such as Crohn's disease explains why gut problems also need prescriber attention, because the product information says extra care applies with severe gut or digestive disease.¹

The honest summary for severe impairment is simple: it may be possible for some people, it is not possible for everyone, and only an individual assessment can tell you which group you are in.

07 · Who should not take it

Conditions that stop or limit treatment

Mounjaro is not suitable for everyone, and kidney disease is only one of many things a prescriber considers. Understanding the full list helps explain why some people are declined and why you should disclose everything.¹

You should not take Mounjaro if you are allergic to tirzepatide or any of its ingredients, and it should not be used during pregnancy or while trying to conceive.¹ Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly. Beyond those firm exclusions, your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy or gallbladder problems.¹ Always share your full medical history and medicine list during consultation.

This matters for people with kidney disease because the conditions often travel together. Diabetic retinopathy is one of the conditions that needs extra care. If your kidney disease is linked to diabetes, expect questions about your eyes as well as your kidneys. Gallbladder history is another point: if you have had your gallbladder removed, our guide on taking Mounjaro without a gallbladder covers it.

There is a thyroid precaution too. In rodent studies tirzepatide caused thyroid C-cell tumours; it is not known whether this applies to humans, and no increase has been shown in human trials. Tell your prescriber if you or a close relative have had medullary thyroid cancer or the inherited condition MEN 2.¹ Routine thyroid monitoring is not required for most people.

Why might you be refused? The realistic reasons fall into a few groups: an allergy, pregnancy or planning pregnancy, a history the prescriber judges makes treatment unsafe, or a medical picture that needs a specialist rather than an online service. If that happens, the order is refunded automatically in full.

If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹ Mounjaro can also reduce absorption of oral contraceptives because stomach emptying slows, as set out in MHRA guidance.⁷ The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹

The takeaway is to be thorough. List every condition and every medicine, including those from your kidney clinic, and let the prescriber decide what matters.

08 · Serious side effects

Serious side effects and when to get help

Serious side effects are uncommon but need urgent attention, and people with kidney disease should know them well because several overlap with situations that already carry kidney risk.¹

Seek immediate medical help for severe, persistent stomach pain that may spread to your back, with or without vomiting, which could be pancreatitis. Seek immediate medical help too for pain in the upper right abdomen, fever or yellowing of the skin or eyes, which could signal gallbladder problems, and for signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing.¹ These are emergencies, not matters to raise at your next review.

Alongside them are the everyday effects most people meet at some stage, particularly nausea, vomiting and bowel changes while the body adjusts. They are usually manageable, yet they are the route by which dehydration can develop, so the sensible line is this: mild and settling, keep drinking and carry on as advised; severe, persistent or leaving you unable to keep fluids down, get medical help straight away.¹

If you take insulin or a sulfonylurea as well, low blood sugar is a further warning to know. Shakiness, sweating and confusion are the signs the product information lists, and your prescriber may need to adjust those medicines.¹ This is a good example of why kidney disease and diabetes together call for a joined-up approach, since people with both are often on several medicines.

Regulators have looked specifically at whether GLP-1 medicines are linked to low mood or suicidal thoughts: the EMA's safety committee reviewed the evidence and concluded in 2024 that it does not support a causal link, and the MHRA keeps this under continuous review.¹⁷

If you have thoughts of harming yourself or ending your life, get help straight away. Call 999 or go to A&E if you are in immediate danger. In England you can call NHS 111 and choose the mental health option, any time. You can also call Samaritans free on 116 123, day or night. Tell your prescriber about any change in your mood while taking Mounjaro.

Finally, if you notice any new symptom that is not listed in the leaflet, do not assume it is unrelated or harmless. Mention it to your prescriber and report it via the Yellow Card scheme.¹⁹ Reporting helps regulators spot patterns that individual patients cannot see.

If you feel seriously unwell, get medical help straight away.

09 · What to expect

What weight management can realistically offer

Treatment alongside diet and exercise produced meaningful average weight loss in trials, but trial averages do not predict your own result. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.²

These are trial averages. Individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.² People with kidney disease should in particular treat them as general reference points, since your own course will depend on your own health and how well you tolerate each step.

Beyond the scales, weight loss on tirzepatide came in trials with average improvements in waist size, blood pressure, cholesterol and blood-sugar measures, and most participants with prediabetes returned to normal blood-sugar levels.² These are trial-average secondary outcomes, not promises, but they are the reason prescribers talk about weight management as health management rather than appearance.

How does the medicine reach these results? Tirzepatide activates the GIP and GLP-1 receptors at once, which helps regulate appetite, slows how quickly the stomach empties and improves the way the body responds to insulin. In practice most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹

Treatment starts on the lowest strength and increases over time through the six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg. Each strength is a pre-filled KwikPen used once weekly.

If you stop, tirzepatide has a half-life of about five days in the body, so after a final dose it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹ Weight regain after stopping is a common worry; discuss a maintenance plan with your prescriber before you finish rather than afterwards.

For the full picture of what a year of treatment can look like, see our weight loss clinic pages.

10 · NHS or private

NHS access or private treatment

Mounjaro is available on the NHS, but access is being phased in over several years.⁴⁶ NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions). Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

If you have kidney disease, the NHS route has a real advantage that a private service cannot match: your GP and kidney team can see your blood results over time and may already know how your body responds to changes. Talk to your GP first if you are in a group likely to be prioritised, and ask whether you are likely to be offered treatment through a specialist weight-management service. Wegovy access, similarly, runs through specialist weight-management services, so ask your GP.

Private treatment suits people who do not yet qualify, who cannot wait for their area to reach them, or who prefer a faster start. Kidney disease needs the same honest declaration, the same attention to fluids and the same prescriber judgement wherever you are treated. A private route should never mean a lighter-touch assessment, and a good provider will tell you so.

With us, the process is straightforward. The consultation is free, and the price shown is the price paid with no hidden fees. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.

Whichever route you take, make sure the person prescribing knows about your kidneys. If you are going private and also under NHS care, tell both teams about all your treatments so nobody works from an incomplete list.

11 · Ordering safely

Ordering safely with kidney disease

A safe order starts with an honest consultation and a regulated pharmacy. Our service is registered with the GPhC (registration 9012878), and you can check that on the GPhC register.¹² That check is worth doing with any online seller, because counterfeit weight-loss injections are a documented risk, and the MHRA publishes alerts about them.⁷ Anyone offering to supply without a consultation or prescription should be avoided, and this is especially important when you have a health condition that makes side effects riskier.

• Free online consultation. A short health questionnaire with no charge and no obligation. Put your kidney disease and every medicine in it.
• Prescriber review. A GPhC-registered prescriber reviews your answers, not a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.
• Dispensing and dispatch. Our registered pharmacy dispenses your pen, with same-day dispatch when ordered by 3pm. Delivery is free, next-day, tracked and discreet in temperature-controlled packaging; Saturday delivery is £14.99.

Needles, a sharps bin and injection guidance come with every order. Repeat orders re-check suitability, and nothing ships automatically, which suits people with kidney disease because your circumstances may change between orders. If your kidney function changes, or you have had an episode of vomiting or dehydration, tell us before reordering rather than after.

Aftercare matters more than the first order. Ongoing monthly reviews, dose-titration and follow-up assessments are carried out by the prescribing team, with side-effect support if you need it. Our support team is available Monday to Friday during office hours by email at support@everydaymeds.co.uk, through the account portal chat or by phone on 0333 207 0413. For anything urgent or out of hours, use NHS urgent services instead.

Storage is straightforward. Keep unopened pens in the fridge at 2–8°C until first use, and they keep until the printed expiry date. Once in use, a KwikPen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use, and must then be thrown away. Do not use a pen that has been above 30°C or has been frozen.¹³

You can also use the free GLPTrackr companion app on iOS or Android to log doses, symptoms and how you are feeling. For someone with kidney disease, a record showing when sickness or diarrhoea began is genuinely useful to show a clinician. Payment can be by Visa or Mastercard, Klarna or pay-monthly options, with no subscriptions.